-
Catalent, Inc. (
Catalent Pharma Solutions) is a
multinational corporation headquartered in Somerset, New Jersey. It is a
global provider of
delivery technologies...
- for example,
starch and carrageenan.
Catalent Pharma Solutions is the
current owner of the
RPScherer technology.
Capsule Catalent Softgel website v t e...
-
developed by
Sarepta Therapeutics,
together with Roche, and is
manufactured by
Catalent.
Delandistrogene moxeparvovec is
indicated for the
treatment of ambulatory...
-
Baden Springs Hotel and the
French Lick
Springs Hotel. In
September 2017,
Catalent purchased Cook
Pharmica for $950 million. In
February 2022, Cook Medical...
- (PDF).
October 1, 2020.
Retrieved October 29, 2020. "Etsy,
Teradyne and
Catalent Set to Join S&P 500;
Others to Join S&P
MidCap 400 and S&P
SmallCap 600"...
-
technology was
developed by R.P.
Scherer Corporation (currently
owned by
Catalent Pharma Solutions) in 1986. The technology's
first commercial application...
- In
February 2024,
parent company Novo
Holdings A/S
agreed to
acquire Catalent for $16.5 billion. On completion, Novo
Nordisk said it
would acquire three...
-
Sarepta Therapeutics' portfolio. In
January 2023,
Sarepta partnered with
Catalent to
manufacture delandistrogene moxeparvovec (SRP-9001). In June 2023, the...
-
subsequently named Catalent Pharma Solutions. "Honoring An Original".
Retrieved 2018-10-18.
Industry on
Parade 36
segment 2 Cardinal.com The
Catalent Pharma Solution...
-
polystyrene sulfonate) powder". fda.gov.
Retrieved 12 July 2015. "Home –
Catalent".
catalent.com.
Retrieved 12 July 2015. "Sorbitol 70%". bttcogroup.in. Archived...
